金融界1月19日消息,
国药一致预计2024年净利润为56,100万元至76,000万元,同比下降52.48%-64.92%;扣非后净利润为49,700万元至69,600万元,同比下降54.59%-67.58%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.